Ulrich W. Beuers

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 252 publications

Reply to 'The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view'.

Reply to 'The ethics of unlicensed therapy use in primary biliary cholangitis: a counter view'.

Journal: Nature reviews. Gastroenterology & hepatology

Published: February 19, 2026

Fracture risk under selective and non-selective PPAR agonists in primary biliary cholangitis.

Fracture risk under selective and non-selective PPAR agonists in primary biliary cholangitis.

Journal: Hepatology communications

Published: February 04, 2026

Children's experience of screening and evaluation for MASLD in overweight and obesity.

Children's experience of screening and evaluation for MASLD in overweight and obesity.

Journal: Obesity research & clinical practice

Published: December 12, 2025

A Nationwide Assessment of Anticholestatic Therapy Uptake in Patients With Primary Biliary Cholangitis: Opportunities for Optimisation.

A Nationwide Assessment of Anticholestatic Therapy Uptake in Patients With Primary Biliary Cholangitis: Opportunities for Optimisation.

Journal: Alimentary pharmacology & therapeutics

Published: November 13, 2025

Prognostic performance of liver stiffness measurements in primary sclerosing cholangitis: the prospective FICUS cohort.

Prognostic performance of liver stiffness measurements in primary sclerosing cholangitis: the prospective FICUS cohort.

Journal: Gastroenterology

Published: November 13, 2025

Bezafibrate for primary biliary cholangitis: time to act on the evidence.

Bezafibrate for primary biliary cholangitis: time to act on the evidence.

Journal: Nature reviews. Gastroenterology & hepatology

Published: October 10, 2025

PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort study.

PD-L1 and the risk of bacterial infection in patients with chronic liver diseases: An international multicohort study.

Journal: JHEP reports : innovation in hepatology

Published: June 28, 2025

Effectiveness and Tolerability of Bezafibrate in Primary Biliary Cholangitis: A Nationwide Real-World Study.

Effectiveness and Tolerability of Bezafibrate in Primary Biliary Cholangitis: A Nationwide Real-World Study.

Journal: The American journal of gastroenterology

Published: June 11, 2025

Effectiveness and tolerability of bezafibrate in primary biliary cholangitis - a nationwide real-world study.

Effectiveness and tolerability of bezafibrate in primary biliary cholangitis - a nationwide real-world study.

Journal: The American journal of gastroenterology

Published: June 11, 2025

Maintenance Treatment for Type 1 Autoimmune Pancreatitis: Effectiveness and Development of the PrescrAIP Relapse Prediction Model.

Maintenance Treatment for Type 1 Autoimmune Pancreatitis: Effectiveness and Development of the PrescrAIP Relapse Prediction Model.

Journal: Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association

Published: June 09, 2025

IgG4-Related Cholangitis.

IgG4-Related Cholangitis.

Journal: Seminars in liver disease

Published: May 09, 2025

The role of bile salts in itch receptor activation.

The role of bile salts in itch receptor activation.

Journal: Biochimica et biophysica acta. Molecular basis of disease

Published: April 10, 2025

Showing 1-12 of 252

Last Updated: 09/26/2026